Menu ×

Rising Healthcare Expenditure to Intensify the Market Growth of Actinic Keratosis Treatment Market

  • Text Size:

Research Nester recently published report titled Flow Cytometry Actinic Keratosis Treatment Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of actinic keratosis treatment market in terms of market segmentation by types, by end users  and by region.

The market is segmented by type into medications and procedures; by end user into hospitals & oncology centers, dermatology clinics and ambulatory surgical center and by region. Hospitals & oncology centers segment is projected to capture the largest market share owing to   ease of accessibility and availability to patients and rise in healthcare infrastructure, especially in developing economies. The actinic keratosis treatment market is anticipated to record a CAGR of around 5.65% during the forecast period i.e. 2019-2027.

Non-profit organizations are conducting awareness programs to spread awareness among the general people regarding the methods of actinic keratosis treatment. The Skin Cancer Foundation has launched an awareness program named “Rays Awareness - Preventing Skin Cancer”, which explains the effect of UV radiation of sun and tanning beds, and their affects on the skin. Similarly, the British Association of Dermatologist also circulated a leaflet explaining the causes of actinic keratosis and their adverse effects.

On the basis of regional analysis, the actinic keratosis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America market is anticipated to capture the largest market share in the actinic keratosis treatment market owing to developing predominance of actinic keratosis, better open mindfulness about event of actinic keratosis and related danger of squamous cell carcinoma.

Abundance of Clinical Data

The abundance of clinical data for actinic keratosis treatment is estimated to aid in the development of novel medications and therapies. The vast amount of clinical data available is being leveraged to understand and develop new and innovative options for effective treatment of actinic keratosis in different patients. Availability of data regarding the treatment is also enabling dermatologists and surgeons to develop customized combination therapies for patients

Combination Therapy

Dermatologists are increasingly adopting a combination of various methods for effectively treating actinic keratosis in patients. The combination of cryotherapy and fluorouracil cream exhibit a success rate of approximately 90% for the treatment of multiple actinic keratosis lesions. The combination of the two treatment offers a variety of benefits such as convenience of application and administration, lower irritability, and enhanced absorption of fluorouracil cream. Clinical trials have suggested enhanced outcome while using the combined therapy compared to the use of cryotherapy and fluorouracil cream individually.

However, lack of skilled worker is anticipated to be a key restraint for the growth of actinic keratosis treatment market during forecast period. The actinic keratosis treatment by photodynamic therapy, cryotherapy or chemical peel requires skilled plastic surgeons. According to the WHO, it is expected to witness a shortage of 12.9 million healthcare workers by 2035 across the globe. The demand for plastic surgery has increased globally whereas the number of plastic surgeons has declined. Besides, the treatment-seeking rate of actinic keratosis is relatively low in developing countries owing to its low awareness among the population.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

This report also provides the existing competitive scenario of some of the key players of actinic keratosis treatment market which includes Tolmar Pharmaceuticals, DUSA Pharmaceuticals, Valeant Pharmaceuticals International, Aqua Pharmaceuticals, LLC, Galderma SA, Perrigo Company LEO Laboratories and other prominent players. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the actinic keratosis treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved